Abstract:Introduction: Glucagon like-peptide 1 receptor (GLP-1R) agonists diminish appetite and may contribute to the weight loss in inflammatory bowel disease (IBD). Objectives: The aim of this study was to determine, for the first time, the expression of GLP-1R by colon nerve fibres in patients with IBD, and functional effects of its agonists in cultured rat and human sensory neurons. Methods: GLP-1R and other nerve markers were studied by immunohistochemistry in colon biopsies from patients with IBD (n = 16) and controls (n = 8), human dorsal root ganglia (DRG) tissue, and in GLP-1R transfected HEK293 cells. The morphological effects of incretin hormones oxyntomodulin, exendin-4 and glucagon were studied on neurite extension in cultured DRG neurons, and their functional effects on capsaicin and ATP signalling, using calcium imaging. Results: Significantly increased numbers of colonic mucosal nerve fibres were observed in IBD biopsies expressing GLP-1R (p = 0.0013), the pan-neuronal marker PGP9.5 (p = 0.0008), and sensory neuropeptide CGRP (p = 0.0014). An increase of GLP-1R positive nerve fibres in IBD colon was confirmed with a different antibody to GLP-1R (p = 0.016). GLP-1R immunostaining was intensely positive in small and medium-sized neurons in human DRG, and in human and rat DRG cultured neurons. Co-localization of GLP-1R expression with neuronal markers in colon and DRG confirmed the neural expression of GLP-1R, and antibody specificity was confirmed in HEK293 cells transfected with the GLP-1R. Treatment with oxyntomodulin, exendin-4 and GLP-1 increased neurite length in cultured neurons compared with controls, but did not stimulate calcium influx directly, or affect capsaicin responses. However, exendin-4 significantly enhanced ATP responses in human DRG neurons. Conclusion: Our results show that increased GLP-1R innervation in IBD bowel could mediate enhanced visceral afferent signalling, and provide a peripheral target for therapeutic intervention. The differential effect of GLP-1R agonists on capsaicin and ATP responses in neurons suggest they may not affect pain mechanisms mediated by the capsaicin receptor TRPV1, but may enhance the effects of purinergic agonists.

Increased GLP2R Expression in Gastric Chief Cells of Patients with Severe Obesity Regardless of Diabetes Status

Glucagon-like peptide-1 and the entero-insular axis in obese hyperglycaemic (ob/ob) mice

Key Pathway And Gene Alterations In The Gastric Mucosa Associated With Obesity And Obesity-Related Diabetes

Central GLP-2 Enhances Hepatic Insulin Sensitivity Via Activating PI3K Signaling in POMC Neurons

[Association of gastric emptying with ghrelin, obestatin and receptor (GHSR, GPR-39) in hypothalamus of diabetic rats]

GLP−1 receptor agonists for the treatment of obesity: Role as a promising approach

A Study on Expression of Stomach Ghrelin and Level of Plasma Ghrelin in the Regular Chow-Induced Obesity-prone and Obesity-resistance-prone Rats

Oleic acid and glucose regulate glucagon-like peptide 1 receptor expression in a rat pancreatic ductal cell line.

Effect of Obesity on the Expression of Nutrient Receptors and Satiety Hormones in the Human Colon

Metabolic and gut microbiome changes following GLP-1 or dual GLP-1/GLP-2 receptor agonist treatment in diet-induced obese mice

Association of Gastric Emptying with Expression of Ghrelin Receptor in Model of Rats with Type 2 Diabetes Meilitus

Changes and clinical significance of plasma brain-gut peptide in obese patients with glycometabolism abnormality

Secretion Of Gut Hormones And Expression Of Sweet Taste Receptors And Glucose Transporters In A Rat Model Of Obesity

Fasting and post prandial pancreatic and enteroendocrine hormone levels in obese and non-obese participants

Glucagon-like peptide 1 receptor (GLP-1R) expression by nerve fibres in inflammatory bowel disease and functional effects in cultured neurons

Effect of GLP-1 analogue on abdominal fat of type 2 diabetic mellitus patients with obesity

GLP-1 increases preingestive satiation via hypothalamic circuits in mice and humans

GLP-1R Agonists Modulate Enteric Immune Responses Through the Intestinal Intraepithelial Lymphocyte GLP-1R

Gastrointestinal Hormone Secretion in Women with Polycystic Ovary Syndrome: an Observational Study

Upregulation of IRS-1 expression in Goto-Kakizaki rats following Roux-en-Y gastric bypass surgery: resolution of type 2 diabetes?

Obesity is Associated with Impaired Postprandial Pancreatic Polypeptide Secretion.